Phenotypic and genotypic changes in Vibrio cholerae O139 Bengal

Journal of Clinical Microbiology

Volumn 35, Issue 10, 1997, Pages 2588-2592

  Albert, M John ^a,b   Bhuiyan, Nurul A ^a   Talukder, Kaisar A ^a   Faruque, A S G ^a   Nahar, Shamsun ^a   Faruque, Shah M ^a   Ansaruzzaman, Mohammad ^a   Rahman, And Mahbubur ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b ICDDRB Laboratory Sciences Division   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIAMINO 6,7 DIISOPROPYLPTERIDINE; COTRIMOXAZOLE; CYCLIC AMP; HEMAGGLUTININ;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISEASE SEVERITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; REHYDRATION; STRAIN DIFFERENCE; VIBRIO CHOLERAE;

BACTERIA (MICROORGANISMS); VIBRIO CHOLERAE;

EID: 0030771427     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.10.2588-2592.1997     Document Type: Article

References (42)

1. Albert, M. J., M. Ansaruzzaman, P. K. Bardhan, A. S. G. Faruque, S. M. Faruque, M. S. Islam, D. Mahalanabis, R. B. Sack, M. A. Salam, A. K. Siddique, M. Yunus, and K. Zaman. 1993. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Lancet 342:384-390.
2. Albert, M. J., N. A. Bhuiyan, A. Rahman, A. N. Ghosh, K. Hultenby, A. Weintraub, S. Nahar, A. K. M. G. Kibriya, M. Ansaruzzaman, and T. Shimada. 1996. Phage specific for Vibrio cholerae O139 Bengal. J. Clin. Microbiol. 34:1843-1845.
3. Albert, M. J., A. K. Siddique, M. S. Islam, A. S. G. Paruque, M. Ansaruzzaman, S. M. Paruque, and R. B. Sack. 1993. Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet 341:704.
4. Altman, D. G. 1991. Practical statistics for medical research. Chapman & Hall, London, United Kingdom.
5. Barrett, T. J., and P. A. Blake. 1981. Epidemiological usefulness of changes in hemolytic activity of Vibrio cholerae biotype El Tor during the seventh pandemic. J. Clin. Microbiol. 13:126-129.
6. Bauer, A. W., W. M. M. Kirby, J. C. Sherris, and M. Turck. 1966. Antibiotic susceptibility testing by a standardized simple disc method. Am. J. Clin. Pathol. 45:493-496.
7. Centers for Disease Control and Prevention. 1993. Imported cholera associated with a newly described toxigenic Vibrio cholerae O139 strain - California, 1993. Morbid. Mortal. Weekly Rep. 42:501-503.
8. Cheasty, T., B. Said, B. Rowe, and J. Frost. 1993. Vibrio cholerae serogroup O139 in England and Wales. Br. Med. J. 307:1007.
9. Chongsa-nguan, M., W. Chaicumpa, P. Moolasart, P. Kandhasingha, T. Shimada, H. Kurazono, and Y. Takeda. 1993. Vibrio cholerae O139 Bengal in Bangkok. Lancet 342:430-431.
10. Damodaran, S., S. Ananthan, and P. Kuganantham. 1995. A retrospective analvsis of the Madras epidemic of non-O1 Vibrio cholerae new serogroup O139 Bengal. Indian J. Med. Res. 101:94-97.
11. Faruque, A. S. G., G. J. Fuchs, and M. J. Albert. 1996. Changing epidemiology of cholera due to Vibrio cholerae O1 and O139 Bengal in Dhaka, Bangladesh. Epidemiol. Infect. 116:275-278.
12. Faruque, A. S. G., D. Mahalanabis, A. Islam, S. S. Hoque, and A. Hasnat. 1993. Common diarrhea pathogens and the risk of dehydration in young children with acute watery diarrhea: a case-control study. Am. J. Trop. Med. Hyg. 49:93-100.
13. Faruque, S. M., K. M. Ahmed, A. R. M. A. Alim, F. Qadri, A. K. Siddique, and M. J. Albert. 1997. Emergence of a new clone of toxigenic Vibrio cholerae O1 biotype El Tor displacing V. cholerae O139 Bengal in Bangladesh. J. Clin. Microbiol. 35:624-630.
14. Fehrenbach, F. J., D. Jürgens, J. Rühlmann, B. Sterzik, and M. Özel. 1988. Role of CAMP-factor (protein B) for virulence, p. 351-357. In F. J. Fehrenbach, J. E. Alouf, P. Falmagne, W. Goebel, J. Jeljaszewicz, and D. Jürgens (ed.), Bacterial protein toxins. Gustav Fischer Verlag, Stuttgart, Germany.
15. Finkelstein, R. A., M. Boesman-Finkelstein, Y. Chang, and C. C. Häse. 1992. Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment. Infect. Immun. 60:472-478.
16. Finkelstein, R. A., M. Boesman-Finkelstein, and P. Holt. 1983. Vibrio cholerae hemagglutinin/lectin/protease hydrolyses fibronectin and ovomucin: F. M. Burnet revisited. Proc. Natl. Acad. Sci. USA 80:1092-1095.
17. Fisher-Hoch, S. P., A. Khan, I. U. Huq, M. A. Khan, and E. D. Mintz. 1993. Vibrio cholerae O139 in Karachi, Pakistan. Lancet 342:1422-1423.
18. Furniss, A. L., J. V. Lee, and T. J. Donovan. 1978. The vibrios, p. 21. Public Health Laboratory Service Monograph Series 11. Her Majesty's Stationery Office, London, United Kingdom.
19. George, V., M. V. Jesudason, and T. J. John. 1996. CAMP test for the identification of Vibrio cholerae O139. Indian J. Med. Res. 103:55-57.
20. Gerbaud, G., A. Dodin, F. Goldstein, and P. Courvalin. 1985. Genetic basis of trimethoprim and O/129 resistance in Vibrio cholerae. Ann. Inst. Pasteur/ Microbiol. (Paris) 136B:265-273.
21. Hall, R. H., F. M. Khambaty, M. H. Kothari, S. P. Keasler, and B. D. Tall. 1994. Vibrio cholerae non-O1 serogroup associated with cholera gravis genetically and physiologically resembles O1 El Tor cholera strains. Infect. Immun. 62:3859-3863.
22. Huq, A., P. A. West, E. B. Small, M. I. Huq, and R. R. Colwell. 1984. Influence of water temperature, salinity, and pH on survival and growth of toxigenic Vibrio cholerae serovar O1 associated with live copepods in laboratory microcosms. Appl. Environ. Microbiol. 48:420-424.
23. Islam, M. S., B. S. Drasar, and R. B. Sack. 1993. The aquatic environment as a reservoir of Vibrio cholerae: a review. J. Diarrhoeal Dis. Res. 11:197-206.
24. Johnson, G., J. Sanchez, and A.-M. Svennerholm. 1989. Expression and detection of different biotype-associated cell-bound haemagglutinins of Vibrio cholerae O1. J. Gen. Microbiol. 135:111-120.
25. Keasler, S. P., and R. H. Hall. 1993. Detecting and biotyping Vibrio cholerae O1 with multiplex polymerase chain reaction. Lancet 341:1661.
26. Kurazono, H., J. Okuda, Y. Takeda, G. B. Nair, M. J. Albert, and R. B. Sack. 1994. Vibrio cholerae O139 Bengal isolated from India, Banlgadesh, and Thailand are clonal as determined by pulsed field gel electrophoresis. J. Infect. 29:109-110.
27. Lesmana, M., M. J. Albert, D. Subekti, E. Richie, P. Tjaniadi, S. E. Walz, and C. I. Lebron. 1996. Simple differentiation of Vibrio cholerae O139 from V. cholerae O1 and non-O1, non-O139 by modified CAMP test. J. Clin. Microbiol. 34:1038-1040.
28. Lesmana, M., D. Subekti, P. Tjaniadi, and G. Pazzaglia. 1994. Modified CAMP test for bigrouping Vibrio cholerae O1 strains and distinguishing them from strains of V. cholerae non-O1. J. Clin. Microbiol. 32:235-237.
29. Monsur, K. A. 1961. A highly selective gelatin-taurocholate-tellurite medium for the isolation of Vibrio cholerae. Trans. R. Soc. Trop. Med. Hyg. 55:440-442.
30. Mukhopadhyay, A. K., S. Garg, R. Mitra, A. Basu, K. Rajendran, D. Dutta, S. K. Bhattacharya, T. Shimada, T. Takeda, Y. Takeda, and G. B. Nair. 1996. Temporal shifts in traits of Vibrio cholerae strains isolated from hospitalized patients in Calcutta: a 3-year (1993 to 1995) analysis. J. Clin. Microbiol. 34:2537-2543.
31. Ramamurthy, T., S. Garg, R. Sharma, S. K. Bhattacharya, G. B. Nair, T. Shimada, T. Takeda, T. Karasawa, H. Kurazono, A. Pal, and Y. Takeda. 1993. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet 341:703-704.
32. Ramamurthy, T., A. Pal, S. C. Pal, and G. B. Nair. 1992. Taxonomical implications of the emergence of high frequency of occurrence of 2,4-diamino-6,7-diisopropylpteridine-resistant strains of Vibrio cholerae from clinical cases of cholera in Calcutta, India. J. Clin. Microbiol. 30:742-743.
33. Shimada, T., E. Arakawa, K. Itoh, T. Nakazata, T. Okitsu, S. Yamai, M. Kusum, G. B. Nair, and Y. Takeda. 1995. Two strains of Vibrio cholerae non-O1 possessing somatic (O) antigen factors in common with V. cholerae serogroup O139 synonym 'Bengal.' Curr. Microbiol. 29:331-333.
34. Siddique, A. K., K. Akram, K. Zaman, P. Mutsuddy, A. Eusof, and R. B. Sack. 1996. Vibrio cholerae O139: how great is the threat of a pandemic? Trop. Med. Int. Health 1:393-398.
35. Smith, C. L., S. R. Klco, and C. R. Cantor. 1988. Pulsed field gel electrophoresis and the technology of large DNA molecules, p. 41-72. In K. Davies (ed.), Genomic analysis: a practical approach. IRL Press, Oxford, United Kingdom.
36. Sokol, P. A., D. E. Ohman, and B. H. Iglewski. 1979. A more sensitive plate assay for detection of protease production by Pseudomonas aeruginosa. J. Clin. Microbiol. 9:538-540.
37. Swerdlow, D. L., and A. A. Ries. 1993. Vibrio cholerae non-O1 - the eighth pandemic? Lancet 342:382-383.
38. Wachsmuth, K., Ø. Olsvik, G. M. Evins, and T. Popovic. 1994. Molecular epidemiology of cholera, p. 357-370. In I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. American Society for Microbiology, Washington D.C.
39. Waldor, M. K., R. Colwell, and J. J. Mekalanos. 1994. The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants. Proc. Natl. Acad. Sci. USA 91:11388-11392.
40. Waldor, M. K., and J. J. Mekalanos. 1994. ToxR regulates virulence gene expression in non-O1 strains of Vibrio cholerae that cause epidemic cholera. Infect. Immun. 62:72-78.
41. Waldor, M. K., H. Tschäpe, and J. J. Mekalanos. 1996. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139. J. Bacteriol. 178: 4157-4165.
42. Yam, W.-C., K.-Y. Yuen, S.-S. Wong, and T.-L. Que. 1994. Vibrio cholerae O139 susceptible to vibriostatic agent O/129 and co-trimoxazole. Lancet 344:404-405.